The United States is home to some of the world’s most influential biotechnology companies. These  organizations are transforming healthcare through breakthroughs in genetic medicine, biologics,  RNA-based therapies, genomics, cancer treatment, and rare disease research. 

Biotechnology combines biological science with advanced technology to develop medicines,  diagnostic tools, and innovative healthcare solutions. From established industry pioneers to  companies developing entirely new therapeutic platforms, the American biotech industry continues  to play a major role in global healthcare innovation. 

In this article, we look at the top 10 biotech companies in the USA based on their innovation,  scientific capabilities, therapeutic impact, industry influence, and contributions to modern medicine. 

Quick Overview 

Rank	Company	Headquarters	Founded	Key Focus Area
1	Amgen	Thousand Oaks, California	1980	Biologics, oncology, and cardiovascular diseases
2	Gilead Sciences	Foster City, California	1987	HIV, antiviral treatments, and oncology
3	Regeneron Pharmaceuticals	Tarrytown, New York	1988	Antibodies, genetics, and immunology
4	Biogen	Cambridge, Massachusetts	1978	Neuroscience and neurological diseases
5	Vertex Pharmaceuticals	Boston, Massachusetts	1989	Cystic fibrosis and genetic diseases
6	Moderna	Cambridge, Massachusetts	2010	mRNA medicines and vaccines
7	Illumina	San Diego, California	1998	DNA sequencing and genomics
8	BioMarin Pharmaceutical	San Rafael, California	1997	Rare and genetic diseases
9	Alnylam Pharmaceuticals	Cambridge, Massachusetts	2002	RNA interference (RNAi) therapeutics
10	CRISPR Therapeutics	Boston, Massachusetts	2013	Gene-editing therapies

1. Amgen 

Amgen is one of the largest and most influential biotechnology companies in the United States.  Founded in 1980, the company is headquartered in Thousand Oaks, California, and played an  important role in establishing the modern biotechnology industry.

Amgen discovers, develops, manufactures, and delivers medicines for serious diseases. Its major  areas of focus include oncology, inflammation, rare diseases, cardiovascular conditions, and general  medicine. 

One of the company’s biggest strengths is its ability to combine biology with advanced technologies  and human genetic data. Amgen continues to invest heavily in research, development, and advanced  manufacturing capabilities. 

Why Amgen Stands Out 

• One of the pioneers of modern biotechnology 

• Strong presence in biologic medicines 

• Major investments in research and development 

• Diverse therapeutic portfolio 

• Strong expertise in manufacturing complex medicines 

2. Gilead Sciences 

Gilead Sciences is a leading American biopharmaceutical company known for developing innovative  therapies for some of the world’s most serious diseases. 

The company focuses primarily on areas such as virology, oncology, and inflammation. Over the  years, Gilead has made major contributions to treatments for HIV, viral hepatitis, cancer, and other  life-threatening conditions. 

Its success has been driven by strong scientific research capabilities and the development of  transformative medicines. The company continues to expand its pipeline across multiple therapeutic  areas. 

Why Gilead Sciences Stands Out 

• Major leader in antiviral therapies 

• Strong oncology research programs 

• Significant global healthcare impact 

• Extensive research and development activities 

• Large portfolio of innovative medicines 

3. Regeneron Pharmaceuticals 

Regeneron Pharmaceuticals is one of America’s most research-driven biotechnology companies.  Founded in 1988, the company is headquartered in Tarrytown, New York. 

Regeneron develops medicines for a wide range of serious diseases, including eye diseases, cancer,  allergic and inflammatory conditions, cardiovascular diseases, neurological disorders, infectious  diseases, and rare diseases. 

A major strength of Regeneron is its focus on translating scientific discoveries into medicines  developed through its research platforms. The company uses advanced antibody technologies and  large-scale genetics research to identify potential disease targets.

Why Regeneron Stands Out 

• Strong science-focused business model 

• Advanced antibody technology platforms 

• Major investment in genetics research 

• Broad therapeutic pipeline 

• Strong internal research capabilities 

4. Biogen 

Biogen is one of the oldest independent biotechnology companies in the United States. Founded in  1978, the company is headquartered in Cambridge, Massachusetts. 

Biogen is particularly well known for its work in neuroscience. The company develops treatments for  neurological and neurodegenerative diseases and has played an important role in advancing  therapies for conditions such as multiple sclerosis. 

The company continues to focus on diseases with significant unmet medical needs while expanding  its scientific and therapeutic capabilities. 

Why Biogen Stands Out 

• Strong leadership in neuroscience 

• Long history in biotechnology 

• Expertise in biologic medicine development 

• Major research and manufacturing capabilities 

• Focus on complex neurological diseases 

5. Vertex Pharmaceuticals 

Vertex Pharmaceuticals is a leading biotechnology company focused on developing transformative  medicines for serious diseases. 

The company is particularly recognized for its groundbreaking work in cystic fibrosis. Vertex has  developed innovative therapies that have significantly changed the treatment landscape for people  living with the disease. 

Beyond cystic fibrosis, Vertex has expanded its research into severe genetic diseases, kidney disease,  pain, and other serious medical conditions. 

Why Vertex Stands Out 

• Global leader in cystic fibrosis treatments 

• Strong focus on genetic diseases 

• Science-driven research strategy 

• Expanding therapeutic pipeline 

• Major presence in the Boston biotechnology ecosystem

6. Moderna 

Moderna is one of the world’s best-known biotechnology companies specializing in messenger RNA,  or mRNA, technology. 

The company develops medicines and vaccines using mRNA technology. This approach uses genetic  instructions to help cells produce proteins that can support different therapeutic and preventive  applications. 

Moderna’s work has demonstrated the enormous potential of mRNA technology. The company  continues to expand its research into infectious diseases, cancer, and other therapeutic areas. 

Why Moderna Stands Out 

• Pioneer in mRNA technology 

• Advanced vaccine development capabilities 

• Strong technology platform 

• Research across multiple therapeutic areas 

• Major influence on the future of genetic medicine 

7. Illumina 

Illumina is different from many traditional biotechnology companies because it focuses heavily on  genomics technology. 

Headquartered in San Diego, California, Illumina develops DNA sequencing and array-based  technologies used by researchers, laboratories, and healthcare organizations worldwide. 

Its technologies help scientists analyze genetic information and support advances in cancer research,  infectious diseases, reproductive health, and personalized medicine. 

Why Illumina Stands Out 

• Global leader in genomics 

• Advanced DNA sequencing technologies 

• Supports cancer and genetic disease research 

• Important role in precision medicine 

• Technology used across life sciences 

8. BioMarin Pharmaceutical 

BioMarin Pharmaceutical specializes in developing medicines for rare and genetically defined  diseases. 

Founded in 1997, the company focuses on developing therapies for patients who often have limited  treatment options. Rare diseases can affect relatively small populations, making them scientifically  challenging to address. 

BioMarin has built its business around applying genetic science and advanced drug development to  these conditions.

Why BioMarin Stands Out 

• Strong focus on rare diseases 

• Expertise in genetic medicine 

• Multiple specialized therapies 

• Research-driven approach 

• Focus on unmet medical needs 

9. Alnylam Pharmaceuticals 

Alnylam Pharmaceuticals is one of the world’s leading companies working with RNA interference,  commonly known as RNAi therapeutics. 

RNA interference is a biological process that can be used to reduce the production of specific  proteins involved in disease. Alnylam played a pioneering role in transforming this scientific concept  into approved medicines. 

The company continues to develop RNA-based therapies for both rare and more common diseases.

Why Alnylam Stands Out 

• Pioneer in RNAi therapeutics 

• Strong expertise in molecular medicine 

• Multiple RNA-based medicines 

• Focus on rare and serious diseases 

• Major influence on RNA biotechnology 

10. CRISPR Therapeutics 

CRISPR Therapeutics is one of the best-known biotechnology companies working in the rapidly  growing field of gene editing. 

The company focuses on using CRISPR-based technologies to develop treatments for serious  diseases. Gene editing has the potential to transform medicine by addressing certain diseases at  their genetic source. 

CRISPR Therapeutics continues to explore applications of gene-editing technology across multiple  disease areas. 

Why CRISPR Therapeutics Stands Out 

• Focus on advanced gene-editing technology 

• Strong scientific innovation 

• Research into genetic diseases 

• Potential to address diseases at their biological source 

• Important player in next-generation medicine

The Future of Biotechnology in the USA 

The biotechnology industry in the United States is entering an exciting period of scientific  development. Technologies such as artificial intelligence, genomics, RNA therapeutics, gene editing,  and advanced biologics are changing how scientists understand and treat diseases. 

1. Precision Medicine 

Treatments are increasingly being designed based on a patient’s genetic and biological  characteristics. 

2. Artificial Intelligence in Drug Discovery 

Artificial intelligence can help researchers analyze complex biological data and identify potential drug  candidates more efficiently. 

3. Growth of Genetic Medicine 

Gene therapies, RNA medicines, and gene-editing technologies could create new treatment options  for previously difficult-to-treat diseases. 

4. Expansion of Biologics 

Biologic medicines continue to be an important area of growth, particularly in cancer, autoimmune  diseases, and rare conditions. 

5. Greater Focus on Rare Diseases 

Companies are increasingly developing specialized medicines for genetically defined and  underserved patient populations. 

Conclusion 

The United States continues to lead the global biotechnology industry because of its strong research  ecosystem, universities, investment environment, and innovative companies. 

Companies such as Amgen, Gilead Sciences, Regeneron, Biogen, Vertex Pharmaceuticals, Moderna,  Illumina, BioMarin, Alnylam Pharmaceuticals, and CRISPR Therapeutics are contributing to the  future of medicine in different ways. 

Some focus on biologic medicines, while others specialize in genomics, RNA technology, rare  diseases, or gene editing. Together, these companies demonstrate the diversity and scientific  strength of the American biotechnology sector. 

As technology continues to advance, biotechnology is expected to play an even greater role in  improving disease prevention, diagnosis, and treatment worldwide. 

FAQs 

1. What are biotechnology companies?

Biotechnology companies use biological science and technology to develop medicines, diagnostic tools, genetic technologies, and other healthcare solutions.

2. Which is the largest biotech company in the USA?

Amgen is widely regarded as one of the largest and most established independent biotechnology companies in the United States.

3. What does a biotech company do?

Biotech companies research and develop products using biological systems. Their work can include medicines, vaccines, gene therapies, diagnostic technologies, and genomics tools.

4. Which US biotech company is known for mRNA technology?

Moderna is one of the best-known biotechnology companies specializing in mRNA-based medicines and vaccines.

5. Which company is a leader in DNA sequencing?

Illumina is one of the world’s leading companies in DNA sequencing and genomics technologies.

6. What is RNAi technology?

RNA interference, or RNAi, is a biological process that can be used to reduce the production of specific proteins associated with diseases.

7. Which biotech company focuses on rare diseases?

BioMarin is particularly known for developing therapies for rare and genetically defined diseases.

8. What is the role of biotechnology in healthcare?

Biotechnology helps develop innovative medicines, improve disease diagnosis, support personalized healthcare, and create new approaches to treating serious illnesses.

9. Why is the USA important to the biotechnology industry?

The United States has major research universities, biotechnology hubs, venture capital investment, advanced healthcare infrastructure, and many leading biotech companies.

10. What is the future of biotechnology?

The future of biotechnology is likely to be shaped by artificial intelligence, genomics, precision medicine, RNA therapeutics, biologics, and gene-editing technologies.